News
An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, investigators ...
Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company engaged in discovering, developing, and ...
Ascentage Pharma (AAPG) announced that two of its proprietary novel drugs have been included in the 2025 Chinese Society of Clinical Oncology, ...
Ascentage Pharma Group International’s AAPG share price has surged by 11.92%, which has investors questioning if this is ...
US drug maker AbbVie has launched its key leukemia drug, Venetoclax, in India, marking its entry into the country's oncology ...
Through the launch of Venetoclax for the treatment of both Acute Myeloid Leukemia (AML) and Chronic Lymphocytic Leukemia (CLL ...
News Medical on MSN1d
Study Suggests Experimental Cancer Drug Could Streamline Standard Tuberculosis Treatment and Prevent Post-TB Lung DiseaseIn a Johns Hopkins Children’s Center study, the addition of navitoclax to the standard TB treatment significantly increased ...
An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback